PHARMACOLOGICAL AND THERAPEUTIC USE OF FUROSEMIDE IN THE MANAGEMENT OF HYPERTENSION

pharmacy

The management of hypertension presents a critical challenge in modern healthcare due to its profound implications for cardiovascular health. This review article delves into the pharmacological and therapeutic utilization of Furosemide in the context of hypertension management. Furosemide, a potent loop diuretic, operates by inhibiting sodium and chloride reabsorption in the ascending loop of Henle, resulting in augmented urinary excretion of electrolytes and fluid. This diuretic action leads to a reduction in intravascular volume, subsequently lowering cardiac output and peripheral resistance, which collectively contribute to blood pressure reduction. The article comprehensively examines the mechanism of action of furosemide and its intricate interaction with the renin-angiotensin-aldosterone system (RAAS), pivotal in sodium and fluid balance regulation. Clinical trials affirm the efficacy of furosemide in decreasing blood pressure in hypertensive patients. Additionally, its role in combination therapy with other antihypertensive agents underscores its significance as an adjunct treatment strategy. Beyond hypertension, furosemide's relevance extends to managing edema associated with cardiac and renal disorders. However, the review also acknowledges potential challenges, including adverse effects such as electrolyte imbalances and dehydration, which necessitate vigilant monitoring and individualized dosing strategies. The abstract concludes by emphasizing the evolving landscape of furosemide-based therapies, accentuating the need for personalized approaches and ongoing research in the pursuit of optimal hypertension management.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.